Modi, A <br/><br/>
Frequency of discontinuation of injectable osteoporosis therapies in US patients over 2 years.  [electronic resource] 

 -  Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA  04 2017 
 - 1355-1363 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1433-2965 
<br/><br/><label>Standard No.: </label>10.1007/s00198-016-3886-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Bone Density Conservation Agents--administration & dosage<br/>Databases, Factual<br/>Denosumab--administration & dosage<br/>Diphosphonates--administration & dosage<br/>Drug Utilization--trends<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Ibandronic Acid<br/>Imidazoles--administration & dosage<br/>Injections, Intravenous<br/>Kaplan-Meier Estimate<br/>Middle Aged<br/>Osteoporosis, Postmenopausal--drug therapy<br/>Retrospective Studies<br/>Teriparatide--administration & dosage<br/>United States<br/>Zoledronic Acid<br/>Assessment of Medication Adherence